Impact Investment Initiative (Triple I)
for Global Health

Partners108

Invest in Global Health. Make an Impact.
Triple I is an ambitious initiative endorsed at the G7 Hiroshima Summit 2023, connecting various stakeholders and mobilizing private capital through impact investment to address global health issues in LMICs.

JOIN US!

News

Feb. 21 2025
- New
- Internal Event
The Fifth Round Table for the Triple I for Global Health
Feb. 13 2025
- New
- Announcement
Triple I Annual Report: September 2023 - September 2024
Jan. 21 2025
- New
- Event
Triple I for GH issued Recommendations for policymakers at its side event in Davos

In recent years, the financial burden of global health has been increasing, especially on low and middle income countries (LMICs). Against this background, the mobilization of private capital through sustainable financing as well as public finance is fundamental in achieving the SDGs by 2030.
At the G7 Hiroshima Summit in 2023, the leaders emphasized the important role of the private sector toward sustainable financing in global health, including through impact investments. The leaders endorsed the “Impact Investment Initiative for Global Health (Triple I for GH)”, an initiative to raise awareness and share best practices on impact investment in global health.
Triple I for GH was launched at the timing of the United Nations General Assembly High Level Meetings in September 2023. Partners of Triple I for GH can demonstrate globally their endeavors to address global health issues and contribute to a more sustainable world while increasing their corporate value.

Mr.Ken Shibusawa

CEO, Shibusawa & Company, Inc.
CEO and Founder, &Capital Inc.
Chairman, Commons Asset Management
Member of the Council on “The New Form of Capitalism”
GSG Japan NAB Chair

Mr.Ken Shibusawa

CEO, Shibusawa & Company, Inc.
CEO and Founder, &Capital Inc.
Chairman, Commons Asset Management
Member of the Council on “The New Form of Capitalism”
GSG Japan NAB Chair

Ken Shibusawa founded in 2001, Shibusawa and Company, Inc., and in 2008, Commons Asset Management. In 2021, he joined Brunswick Group as senior advisor.
He has extensive market experience at JP Morgan, Goldman Sachs, and Moore Capital, a global macro hedge fund, where he was the representative managing director of the Tokyo Office. He is also co-chair of Global South-Africa Committee at Keizai Doyukai (Japan Association of Corporate Executives), advisor to the Office of the President at the University of Tokyo, member of various government panels, including Prime Minister Kishida’s Council on New Capitalism, and a steering group member of UNDP SDG Impact.
In 2022, he was named as board member of the newly founded International Foundation for Valuing Impact, as special advisor to the ISSB (International Sustainability Standards Boards) chair. In 2023, he founded &Capital, Inc., an impact fund management company for Africa.
Mr. Steve Davis

Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Bill & Melinda Gates Foundation.
Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
Member of the Council on Foreign Relations

Mr. Steve Davis

Senior Advisor and Interim Director of the Philanthropic Partnerships Team, Bill & Melinda Gates Foundation.
Stanford Graduate School of Business Lecturer and Global Health Faculty Fellow,
Member of the Council on Foreign Relations

Steve Davis serves as a Senior Advisor and Interim Director of the Philanthropic Partnerships Team at Bill & Melinda Gates Foundation, as a Lecturer at the Stanford Graduate School of Business, and as a member of the Council on Foreign Relations. Steve has deep experience, and sits on numerous boards and advisory groups, focused on the intersection of business, innovation, and social impact. He most recently served as Senior Advisor for McKinsey & Company. Before that, he was Executive Strategic Advisor and Interim Director, China Country Office, for the Bill & Melinda Gates Foundation, co-chair of the World Health Organization's Digital Health Technical Advisory Group, and Distinguished Fellow for the World Economic Forum. Steve is also the former President & CEO of PATH, a leading global health innovation organization; former Director of Social Innovation at McKinsey; former CEO of Corbis, a digital media pioneer; and as an attorney with K&L Gates. With degrees from Princeton University, University of Washington, and Columbia Law School, Steve also is the author of Undercurrents: Channeling Outrage to Spark Practical Activism (Wiley 2020), and speaks and writes frequently on topics related to corporate engagement in social impact, social innovation, and digital health . He lives with his family in Seattle, Washington.
Dr. Ayoade Alakija

The board chair of FIND,
the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

Dr. Ayoade Alakija

The board chair of FIND,
the World Health Organization (WHO) Special Envoy for the Access to COVID-19 Tools (ACT) Accelerator, and co-chairs the Principals Group.

Dr. Ayoade Alakija is a renowned global health leader with expertise in pandemic preparedness and health security and diplomacy. With over two decades in the field, her dedication to equitable access became especially pronounced during COVID-19. As FIND's board chair and the WHO Special Envoy for the ACT-Accelerator, she focuses on creating transformative impacts, particularly for the Global South.

In her role as Nigeria's Chief Humanitarian Coordinator, she adeptly managed responses to humanitarian crises, and steered the Oslo Humanitarian Conference for Nigeria and the Lake Chad region. As the Chair of the African Vaccine Delivery Alliance, she has been pivotal in championing Africa's voice for access to medical countermeasures.

Dr. Alakija is a staunch advocate for women's equity, believing in investing in women not just as a gender initiative but as a profitable business decision. Her voice consistently champions justice, echoing both in influential boardrooms and at the grassroots level.